Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2)

Radiation Research

Volumn 169, Issue 1, 2008, Pages 67-75

  Wen, Bixiu ^a   Urano, Muneyasu ^a   Humm, John L ^a   Seshan, Venkatraman E ^b   Li, Gloria C ^a   Ling, C Clifton ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FIBER OPTICS; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; TUMOR; ANIMAL; CANCER TRANSPLANTATION; COMPARATIVE STUDY; HUMAN; METABOLISM; NEOPLASM; NUDE MOUSE; PATHOLOGY; PRESSURE;

ANIMALIA;

OXYGEN;

ANIMALS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; OXYGEN; PARTIAL PRESSURE;

EID: 39049089019     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0888.1     Document Type: Article

References (34)

1. L. Holmquist, A. Jogi and S. Pahlman, Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells. Int. J. Cancer 116, 218-225 (2005).
2. K. Helczynska, A. Kronblad, A. Jogi, E. Nilsson, S. Beckman, G. Landberg and S. Pahlman, Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res. 63, 1441-1444 (2003).
3. M. A. Ghafar, A. G. Anastasiadis, M. W. Chen, M. Burchardt, L. E. Olsson, H. Xie, M. C. Benson and R. Buttyan, Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate 54, 58-67 (2003).
4. E. Lartigau, A. M. Le Ridant, P. Lambin, P. Weeger, L. Martin, R. Sigal, A. Lusinchi, B. Luboinski, F. Eschwege and M. Guichard, Oxygenation of head and neck tumors. Cancer 71, 2319-2325 (1993).
5. M. Hockel and P. Vaupel, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93, 266-276 (2001).
6. M. Nordsmark, S. M. Bentzen, V. Rudat, D. Brizel, E. Lartigau, P. Stadler, A. Becker, M. Adam, M. Molls and J. Overgaard, Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother. Oncol. 77, 18-24 (2005).
7. R. A. Gatenby, H. B. Kessler, J. S. Rosenblum, L. R. Coia, P. J. Moldofsky, W. H. Hartz and G. J. Broder, Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14, 831-838 (1988).
8. 2 tension measurements. Cancer Res. 51, 3316-3322 (1991).
9. A. Fyles, M. Milosevic, D. Hedley, M. Pintilie, W. Levin, L. Manchul and R. P. Hill, Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J. Clin. Oncol. 20, 680-687 (2002).
10. D. M. Brizel, S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz and M. W. Dewhirst, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943 (1996).
11. 2 using the OxyLite system in R3327-AT tumors under isoflurane anesthesia. Radiat. Res. 166, 512-518 (2006).
12. J. Bussink, J. H. Kaanders, A. M. Strik, B. Vojnovic and A. J. van der Kogel, Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines. Radiat. Res. 154, 547-555 (2000).
13. Q. T. Le, M. S. Kovacs, M. J. Dorie, A. Koong, D. J. Terris, H. A. Pinto, D. R. Goffinet, K. Nowels, D. Bloch and J. M. Brown, Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 56, 375-383 (2003).
14. M. Urano, Y. Chen, J. Humm, J. A. Koutcher, P. Zanzonico and C. Ling, Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical OxyLite probe: Comparison with a paired survival assay. Radiat. Res. 158, 167-173 (2002).
15. M. J. Dorie and J. M. Brown, Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine. Cancer Chemother. Pharmacol. 39, 361-366 (1997).
16. C. J. Koch and S. M. Evans, Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles. Adv. Exp. Med. Biol. 510, 285-292 (2003).
17. S. M. Evans, S. Hahn, D. R. Pook, W. T. Jenkins, A. A. Chalian, P. Zhang, C. Stevens, R. Weber, G. Weinstein and C. J. Koch, Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 60, 2018-2024 (2000).
18. P. F. Rijken, H. J. Bernsen, J. P. Peters, R. J. Hodgkiss, J. A. Raleigh and A. J. van der Kogel, Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int. J. Radiat. Oncol. Biol. Phys. 48, 571-582 (2000).
19. P. Zanzonico, J. O'Donoghue, J. D. Chapman, R. Schneider, S. Cai, S. Larson, B. Wen, Y. Chen, R. Finn and C. Ling, Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning. Eur. J. Nucl. Med. Mol. Imaging 31, 117-128 (2004).
20. 2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models. Int. J. Radiat. Oncol. Biol. Phys. 61, 1493-1502 (2005).
21. M. Krengli, A. Ballare, B. Cannillo, M. Rudoni, E. Kocjancic, G. Loi, M. Brambilla, E. Inglese and B. Frea, Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 66, 1100-1104 (2006).
22. B. Wen, P. Burgman, P. Zanzonico, J. O'Donoghue, S. Cai, R. Finn, I. Serganova, R. Blasberg, J. Gelovani and C. C. Ling, A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia. Eur. J. Nucl. Med. Mol. Imaging 31, 1530-1538 (2004).
23. 18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure. Appl. Radiat. Isot. 54, 73-80 (2001).
24. 18F-EF5. Eur. J. Nucl. Med. Mol. Imaging 30, 259-266 (2003).
25. J. S. Lewis, T. L. Sharp, R. Laforest, Y. Fujibayashi and M. J. Welch, Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J. Nucl. Med. 42, 655-661 (2001).
26. J. D. Chapman, L. R. Coia, C. C. Stobbe, E. L. Engelhardt, M. C. Fenning and R. F. Schneider, Prediction of tumour hypoxia and radioresistance with nuclear medicine markers. Br J. Cancer Suppl. 27, S204-S208 (1996).
27. B. M. Seddon, D. J. Honess, B. Vojnovic, G. M. Tozer and P. Workman, Measurement of tumor oxygenation: In vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p22 tumor. Radiat. Res. 155, 837-846 (2001).
28. R. D. Braun, J. L. Lanzen, S. A. Snyder and M. W. Dewhirst, Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am J. Physiol. Heart Circ. Physiol. 280, H2533-H2544 (2001).
29. 2 microelectrodes. J. Appl. Physiol. 63, 2554-2557 (1987).
30. B. Clavo, J. L. Perez, L. Lopez, G. Suarez, M. Lloret, V. Rodriguez, D. Macias, M. Santana, J. Morera and M. Günderoth, Effect of ozone therapy on muscle oxygenation. J. Altern. Complement. Med. 9, 251-256 (2003).
31. 2 concentrations. Adv. Exp. Med. Biol. 428, 79-87 (1997).
32. B. W. Silverman, Density Estimation for Statistics and Data Analysis. Chapman & Hall, New York, 1986.
33. J. Bussink, J. H. Kaanders, A. M. Strik and A. J. van der Kogel, Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes. Radiother. Oncol. 57, 21-30 (2000).
34. W. K. Young, B. Vojnovic and P. Wardman, Measurement of oxygen tension in tumours by time-resolved fluorescence. Br J. Cancer Suppl. 27, S256-S259 (1996).